An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Open accessThe DOI matches its Crossref record; 324 of the 325 references it cites were found in a registry or an index.
Abstract
This document is an international evidence-based guideline on the diagnosis and management of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association. It represents the current state of knowledge regarding idiopathic pulmonary fibrosis (IPF), and contains sections on definition and epidemiology, risk factors, diagnosis, natural history, staging and prognosis, treatment, and monitoring disease course. For the diagnosis and treatment sections, pragmatic GRADE evidence-based methodology was applied in a question-based format. For each diagnosis and treatment question, the committee graded the quality of the evidence available (high, moderate, low, or very low), and made a recommendation (yes or no, strong or weak). Recommendations were based on majority vote. It is emphasized that clinicians must spend adequate time with patients to discuss patients' values and preferences and decide on the appropriate course of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, all patients originally gathered from hospital register using ICD-10 codes were meticulously re-assessed and re-classified using the year 2011 criteria, and the cases representing some other type of ILDs were excluded [14].”
From Comparison of disease progression subgroups in idiopathic pulmonary fibrosis (2019) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ILD still has a poor prognosis and the highest mortality rate during lung transplantation.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interstitial lung disease (ILD) remains an important indication for lung transplantation, and the number of patients with this disease is increasing.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Idiopathic pulmonary fibrosis (IPF), characterized histopathologically and/or radiologically with a usual interstitial pneumonia (UIP) pattern, is the most common adult form of interstitial pneumonia of unknown origin [1].”
From Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature (2014) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The median survival time for patients with IPF is 2 to 3 years from diagnosis and the 5-year survival rate ranges between 30% and 50% [1,5-7].”
From Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature (2014) · cites this paper as [1]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Crapo, R., Enright, P., van der Grinten, C. P. M., Gustafsson, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034805 · Cited by 15,627
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Interpretative strategies for lung function tests
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035205 · Cited by 5,945
Fleischner Society: Glossary of Terms for Thoracic Imaging
Hansell, D. M., Bankier, A. A., MacMahon, H., McLoud, T. C., Müller, N. L., & Remy, J. (2008) · Radiology · doi:10.1148/radiol.2462070712 · Cited by 4,198
Self-citation(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Standardisation of the measurement of lung volumes
Wanger, J., Clausen, J. L., Coates, A., Pedersen, O. F., Brusasco, V., Burgos, F., Casaburi, R., Crapo, R., Enright, P., van der Grinten, C. P. M., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035005 · Cited by 2,768
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Standardisation of the single-breath determination of carbon monoxide uptake in the lung
MacIntyre, N., Crapo, R. O., Viegi, G., Johnson, D. C., van der Grinten, C. P. M., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Enright, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034905 · Cited by 2,255
NOCTURNAL OXYGEN THERAPY TRIAL GROUP* (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-3-391 · Cited by 2,218
Research works printed but not linked: 9
- Cochrane Handbook for Systematic Reviews of Interventions 5.0.2. Oxford: The Cochrane Collaboration, 2009. [online] 2009. [accessed 20 June 2010]; Available from: http://www.cochrane.org/resources/handbook/.
- Nadrous HF, Ryu JH, Douglas WW, Decker PA, Olson EJ. Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis. Chest 2004;126:438–446. [DOI] [PubMed] [Google Scholar]
- 2005, J Gastrointest Surg, 1053
- Marshall RP, Puddicombe A, Cookson WO, Laurent GJ. Adult familial cryptogenic fibrosing alveolitis in the UK. Thorax 2000;55:143–146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001;345:517–525. [DOI] [PubMed] [Google Scholar]
- Kondo A, Saiki S. Acute exacerbation in idiopathic interstitial pneumonia (IIP). In: Harasawa M, Fukuchi Y, Morinari H, editors. Interstitial pneumonia of unknown etiology. Tokyo: University of Tokyo Press; 1989. pp. 33–42.
- Flaherty KR, Colby TV, Toews GB, Travis WD, Flint A, Gay SE, Strawderman RL III, Jain A, Lynch JP III, Martinez FJ. Differential presence of fibroblastic foci in UIP patients with or without conntective tissue disease. Am J Respir Crit Care Med 2001;163:A983. [Google Scholar]
- Molina-Molina M, Badia JR, Marin-Arguedas A, Xaubet A, Santos MJ, Nicolas JM, Ferrer M, Torres A. Outcomes and clinical characteristics of patients with pulmonary fibrosis and respiratory failure admitted to an intensive care unit: a study of 20 cases. Med Clin (Barc) 2003;121:63–67. [DOI] [PubMed] [Google Scholar]
- Pitsiou G, Ioannis Trigonis I, Tsiata E, Kontou P, Manolakoglou N, Stanopoulos I, Mavrofridis E, Argyropoulou P. Outcome of patients with pulmonary fibrosis admitted to the ICU for acute respiratory failure. Eur Respir J Suppl 2006;28:E650. [Google Scholar]
Cited by
Items 301–400 of 1,060
Sonic Hedgehog Signaling in the Lung. From Development to Disease
Kugler, M. C., Joyner, A. L., Loomis, C. A., & Munger, J. S. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0132tr · Cited by 177
Madala, S. K., Schmidt, S., Davidson, C. R., Ikegami, M., Wert, S. E., & Hardie, W. D. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0237oc · Cited by 177
Incidence and prevalence of interstitial lung diseases worldwide: a systematic literature review
Gupta, R. S., Koteci, A., Morgan, A. D., George, P. M., & Quint, J. K. (2023) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2022-001291 · Cited by 176
Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer
Tzouvelekis, A., Gomatou, G., Bouros, E., Trigidou, R., Tzilas, V., & Bouros, D. (2019) · Chest · doi:10.1016/j.chest.2019.04.114 · Cited by 176
Self-citationWilliamson, J. D., Sadofsky, L. R., & Hart, S. P. (2014) · Experimental Lung Research · doi:10.3109/01902148.2014.979516 · Cited by 176
Molecular Mechanisms of Pulmonary Fibrogenesis and Its Progression to Lung Cancer: A Review
Kinoshita, T., & Goto, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061461 · Cited by 176
Hozumi, H., Fujisawa, T., Nakashima, R., Johkoh, T., Sumikawa, H., Murakami, A., Enomoto, N., Inui, N., Nakamura, Y., Hosono, Y., et al. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.10.019 · Cited by 176
Self-citationHerazo-Maya, J. D., Sun, J., Molyneaux, P. L., Li, Q., Villalba, J. A., Tzouvelekis, A., Lynn, H., Juan-Guardela, B. M., Risquez, C., Osorio, J. C., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30349-1 · Cited by 175
Raghu, G., Scholand, M. B., de Andrade, J., Lancaster, L., Mageto, Y., Goldin, J., Brown, K. K., Flaherty, K. R., Wencel, M., Wanger, J., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01030-2015 · Cited by 175
Self-citationSafety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis
Corte, T., Bonella, F., Crestani, B., Demedts, M. G., Richeldi, L., Coeck, C., Pelling, K., Quaresma, M., & Lasky, J. A. (2015) · Respiratory Research · doi:10.1186/s12931-015-0276-5 · Cited by 175
Self-citationDésogère, P., Tapias, L. F., Hariri, L. P., Rotile, N. J., Rietz, T. A., Probst, C. K., Blasi, F., Day, H., Mino-Kenudson, M., Weinreb, P., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf4696 · Cited by 175
Chung, J. H., Chawla, A., Peljto, A. L., Cool, C. D., Groshong, S. D., Talbert, J. L., McKean, D. F., Brown, K. K., Fingerlin, T. E., Schwarz, M. I., et al. (2015) · Chest · doi:10.1378/chest.14-0976 · Cited by 175
Self-citationA review of current and novel therapies for idiopathic pulmonary fibrosis.
Rafii, R., Juarez, M. M., Albertson, T. E., & Chan, A. L. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2012.12.07 · Cited by 175
Risk factors for diagnostic delay in idiopathic pulmonary fibrosis
Hoyer, N., Prior, T. S., Bendstrup, E. M., Wilcke, T., & Shaker, S. B. (2019) · Respiratory Research · doi:10.1186/s12931-019-1076-0 · Cited by 175
Windisch, W., Dreher, M., Geiseler, J., Siemon, K., Brambring, J., Dellweg, D., Grolle, B., Hirschfeld, S., Köhnlein, T., Mellies, U., et al. (2017) · Pneumologie · doi:10.1055/s-0043-118040 · Cited by 175
Variability in Global Prevalence of Interstitial Lung Disease
Kaul, B., Cottin, V., Collard, H. R., & Valenzuela, C. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.751181 · Cited by 175
Self-citationRyerson, C. J., Cayou, C., Topp, F., Hilling, L., Camp, P. G., Wilcox, P. G., Khalil, N., Collard, H. R., & Garvey, C. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2013.11.016 · Cited by 174
Self-citationNewton, C. A., Oldham, J. M., Ley, B., Anand, V., Adegunsoye, A., Liu, G., Batra, K., Torrealba, J., Kozlitina, J., Glazer, C., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01641-2018 · Cited by 174
Respiratory Impairment and the Aging Lung: A Novel Paradigm for Assessing Pulmonary Function
Vaz Fragoso, C. A., & Gill, T. M. (2012) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glr198 · Cited by 174
Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis
Newton, C. A., Zhang, D., Oldham, J. M., Kozlitina, J., Ma, S.-F., Martinez, F. J., Raghu, G., Noth, I., & Garcia, C. K. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201809-1646oc · Cited by 173
Self-citationIdiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural history
Sgalla, G., Biffi, A., & Richeldi, L. (2016) · Respirology · doi:10.1111/resp.12683 · Cited by 173
Self-citationVainshelboim, B., Oliveira, J., Yehoshua, L., Weiss, I., Fox, B. D., Fruchter, O., & Kramer, M. R. (2014) · Respiration · doi:10.1159/000367899 · Cited by 173
Winterbottom, C. J., Shah, R. J., Patterson, K. C., Kreider, M. E., Panettieri, R. A., Rivera-Lebron, B., Miller, W. T., Litzky, L. A., Penning, T. M., Heinlen, K., et al. (2018) · Chest · doi:10.1016/j.chest.2017.07.034 · Cited by 173
Acute exacerbations of fibrotic interstitial lung diseases
Suzuki, A., Kondoh, Y., Brown, K. K., Johkoh, T., Kataoka, K., Fukuoka, J., Kimura, T., Matsuda, T., Yokoyama, T., Fukihara, J., et al. (2020) · Respirology · doi:10.1111/resp.13682 · Cited by 173
Self-citationMolecular biomarkers in idiopathic pulmonary fibrosis
Ley, B., Brown, K. K., & Collard, H. R. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00014.2014 · Cited by 172
Self-citationSelvarajah, B., Azuelos, I., Platé, M., Guillotin, D., Forty, E. J., Contento, G., Woodcock, H. V., Redding, M., Taylor, A., Brunori, G., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aav3048 · Cited by 172
Ryu, C., Sun, H., Gulati, M., Herazo-Maya, J. D., Chen, Y., Osafo-Addo, A., Brandsdorfer, C., Winkler, J., Blaul, C., Faunce, J., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201612-2480oc · Cited by 171
Acute Exacerbation in Interstitial Lung Disease
Leuschner, G., & Behr, J. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00176 · Cited by 171
Self-citationA cohort study of interstitial lung diseases in central Denmark
Hyldgaard, C., Hilberg, O., Muller, A., & Bendstrup, E. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2013.09.002 · Cited by 171
Inui, N., Sakai, S., & Kitagawa, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116107 · Cited by 169
Röhrich, M., Leitz, D., Glatting, F. M., Wefers, A. K., Weinheimer, O., Flechsig, P., Kahn, N., Mall, M. A., Giesel, F. L., Kratochwil, C., et al. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.261925 · Cited by 169
Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis
Mermigkis, C. M., Bouloukaki, I., Antoniou, K. M., Papadogiannis, G., Giannarakis, I., Varouchakis, G., Siafakas, N. M., & Schiza, S. E. (2014) · Sleep And Breathing · doi:10.1007/s11325-014-1033-6 · Cited by 169
Rogliani, P., Calzetta, L., Cavalli, F., Matera, M. G., & Cazzola, M. (2016) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2016.07.009 · Cited by 168
Quantitative CT Analysis of Diffuse Lung Disease
Chen, A., Karwoski, R. A., Gierada, D. S., Bartholmai, B. J., & Koo, C. W. (2020) · RadioGraphics · doi:10.1148/rg.2020190099 · Cited by 168
Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997–2008
Hutchinson, J. P., McKeever, T. M., Fogarty, A. W., Navaratnam, V., & Hubbard, R. B. (2016) · European Respiratory Journal · doi:10.1183/13993003.00378-2016 · Cited by 167
Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease
Holland, A. E., Fiore, J. F., Bell, E. C., Goh, N., Westall, G., Symons, K., Dowman, L., & Glaspole, I. (2014) · Respirology · doi:10.1111/resp.12360 · Cited by 167
Albera, C., Costabel, U., Fagan, E. A., Glassberg, M. K., Gorina, E., Lancaster, L., Lederer, D. J., Nathan, S. D., Spirig, D., & Swigris, J. J. (2016) · European Respiratory Journal · doi:10.1183/13993003.01966-2015 · Cited by 166
Self-citationSubclinical Interstitial Lung Disease: Why You Should Care
Doyle, T. J., Hunninghake, G. M., & Rosas, I. O. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201108-1420pp · Cited by 166
Palliative Care and Location of Death in Decedents With Idiopathic Pulmonary Fibrosis
Lindell, K. O., Liang, Z., Hoffman, L. A., Rosenzweig, M. Q., Saul, M. I., Pilewski, J. M., Gibson, K. F., & Kaminski, N. (2015) · Chest · doi:10.1378/chest.14-1127 · Cited by 165
Computer-Aided Diagnosis of Pulmonary Fibrosis Using Deep Learning and CT Images
Christe, A., Peters, A. A., Drakopoulos, D., Heverhagen, J. T., Geiser, T., Stathopoulou, T., Christodoulidis, S., Anthimopoulos, M., Mougiakakou, S. G., & Ebner, L. (2019) · Investigative Radiology · doi:10.1097/rli.0000000000000574 · Cited by 165
Wang, P., Jones, K. D., Urisman, A., Elicker, B. M., Urbania, T., Johannson, K. A., Assayag, D., Lee, J., Wolters, P. J., Collard, H. R., et al. (2017) · Chest · doi:10.1016/j.chest.2017.02.011 · Cited by 165
Self-citationLipid Mediators Regulate Pulmonary Fibrosis: Potential Mechanisms and Signaling Pathways
Suryadevara, V., Ramchandran, R., Kamp, D. W., & Natarajan, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124257 · Cited by 165
Confalonieri, P., Volpe, M. C., Jacob, J., Maiocchi, S., Salton, F., Ruaro, B., Confalonieri, M., & Braga, L. (2022) · Cells · doi:10.3390/cells11132095 · Cited by 164
Aspiration-Related Pulmonary Syndromes
Hu, X., Lee, J. S., Pianosi, P. T., & Ryu, J. H. (2015) · CHEST Journal · doi:10.1378/chest.14-1049 · Cited by 164
Self-citationFibroblast senescence in the pathology of idiopathic pulmonary fibrosis
Waters, D. W., Blokland, K. E. C., Pathinayake, P. S., Burgess, J. K., Mutsaers, S. E., Prele, C. M., Schuliga, M., Grainge, C. L., & Knight, D. A. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00037.2018 · Cited by 163
Artaud-Macari, E., Goven, D., Brayer, S., Hamimi, A., Besnard, V., Marchal-Somme, J., Ali, Z. E., Crestani, B., Kerdine-Römer, S., Boutten, A., et al. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4240 · Cited by 163
Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis
Tjin, G., White, E. S., Faiz, A., Sicard, D., Tschumperlin, D. J., Mahar, A., Kable, E. P. W., & Burgess, J. K. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.030114 · Cited by 163
Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction
Raghu, G., Nathan, S. D., Behr, J., Brown, K. K., Egan, J. J., Kawut, S. M., Flaherty, K. R., Martinez, F. J., Wells, A. U., Shao, L., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01537-2014 · Cited by 163
Self-citationMatrices of Physiologic Stiffness Potently Inactivate Idiopathic Pulmonary Fibrosis Fibroblasts
Marinković, A., Liu, F., & Tschumperlin, D. J. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0335oc · Cited by 163
Leslie, K. O. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0511-oa · Cited by 163
Chung, J. H., Cox, C. W., Montner, S. M., Adegunsoye, A., Oldham, J. M., Husain, A. N., Vij, R., Noth, I., Lynch, D. A., & Strek, M. E. (2018) · American Journal of Roentgenology · doi:10.2214/ajr.17.18384 · Cited by 163
Self-citationHeterozygous RTEL1 mutations are associated with familial pulmonary fibrosis
Kannengiesser, C., Borie, R., Ménard, C., Réocreux, M., Nitschké, P., Gazal, S., Mal, H., Taillé, C., Cadranel, J., Nunes, H., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00040115 · Cited by 162
Self-citationAhmad, K., Barba, T., Gamondes, D., Ginoux, M., Khouatra, C., Spagnolo, P., Strek, M. E., Thivolet-Béjui, F., Traclet, J., & Cottin, V. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.10.017 · Cited by 162
Using hyperpolarized 129Xe MRI to quantify regional gas transfer in idiopathic pulmonary fibrosis
Wang, J. M., Robertson, S. H., Wang, Z., He, M., Virgincar, R. S., Schrank, G. M., Smigla, R. M., O’Riordan, T. G., Sundy, J., Ebner, L., et al. (2018) · Thorax · doi:10.1136/thoraxjnl-2017-210070 · Cited by 162
Delbrel, E., Soumare, A., Naguez, A., Label, R., Bernard, O., Bruhat, A., Fafournoux, P., Tremblais, G., Marchant, D., Gille, T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-36063-2 · Cited by 162
ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis
Lagares, D., Ghassemi-Kakroodi, P., Tremblay, C., Santos, A., Probst, C. K., Franklin, A., Santos, D. M., Grasberger, P., Ahluwalia, N., Montesi, S. B., et al. (2017) · Nature Medicine · doi:10.1038/nm.4419 · Cited by 162
Self-citationJones, M. G., Andriotis, O. G., Roberts, J. J., Lunn, K., Tear, V. J., Cao, L., Ask, K., Smart, D. E., Bonfanti, A., Johnson, P., et al. (2018) · eLife · doi:10.7554/elife.36354 · Cited by 162
Self-citationBronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful?
Meyer, K. C., & Raghu, G. (2011) · European Respiratory Journal · doi:10.1183/09031936.00069509 · Cited by 162
Self-citationAdegunsoye, A., Oldham, J. M., Bellam, S. K., Montner, S., Churpek, M. M., Noth, I., Vij, R., Strek, M. E., & Chung, J. H. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201807-443oc · Cited by 161
Fois, A. G., Paliogiannis, P., Sotgia, S., Mangoni, A. A., Zinellu, E., Pirina, P., Carru, C., & Zinellu, A. (2018) · Respiratory Research · doi:10.1186/s12931-018-0754-7 · Cited by 161
Choe, J., Hwang, H. J., Seo, J. B., Lee, S. M., Yun, J., Kim, M.-J., Jeong, J., Lee, Y., Jin, K., Park, R., et al. (2021) · Radiology · doi:10.1148/radiol.2021204164 · Cited by 160
Sleep Oxygen Desaturation Predicts Survival in Idiopathic Pulmonary Fibrosis
Kolilekas, L., Manali, E. D., Vlami, K., Lyberopoulos, P., Triantafillidou, C., Kagouridis, K., Baou, K., Gyftopoulos, S., Vougas, K. N., Karakatsani, A., et al. (2013) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.2758 · Cited by 159
Lentz, R. J., Argento, A. C., Colby, T. V., Rickman, O. B., & Maldonado, F. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.06.96 · Cited by 159
Self-citationBronchoscopic Cryobiopsy for the Diagnosis of Diffuse Parenchymal Lung Disease
Kropski, J. A., Pritchett, J. M., Mason, W. R., Sivarajan, L., Gleaves, L. A., Johnson, J. E., LANCASTER, L. H., Lawson, W. E., Blackwell, T. S., Steele, M. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078674 · Cited by 159
Satō, T., Watanabe, A., Kondo, H., Kanzaki, M., Okubo, K., Yokoi, K., Matsumoto, K., Marutsuka, T., Shinohara, H., Teramukai, S., et al. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.08.086 · Cited by 159
Self-citationIftikhar, I. H., Alghothani, L., Sardi, A. H., Berkowitz, D. M., & Musani, A. I. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201701-086sr · Cited by 159
Fernández-Díaz, C., Loricera, J., Castañeda, S., López‐Mejías, R., Ojeda-García, C., Olivé, A., Rodríguez‐Muguruza, S., Carreira, P. E., Pérez-Sandoval, T., Retuerto, M., et al. (2018) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2017.12.012 · Cited by 159
Sisson, T. H., Ajayi, I. O., Subbotina, N., Dodi, A. E., Rodansky, E. S., Chibucos, L. N., Kim, K. K., Keshamouni, V. G., White, E. S., Zhou, Y., et al. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.12.005 · Cited by 158
Averyanov, A., Koroleva, I., Konoplyannikov, M., Revkova, V., Lesnyak, V., Kalsin, V., Danilevskaya, O., Nikitin, A., Sotnikova, A., Kotova, S., et al. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0037 · Cited by 158
YouTube Videos as a Source of Misinformation on Idiopathic Pulmonary Fibrosis
Goobie, G. C., Guler, S. A., Johannson, K. A., Fisher, J. H., & Ryerson, C. J. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201809-644oc · Cited by 158
Raghu, G., Flaherty, K. R., Lederer, D. J., Lynch, D. A., Colby, T. V., Myers, J. L., Groshong, S. D., Larsen, B. T., Chung, J. H., Steele, M. P., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30059-1 · Cited by 157
Self-citationSeipin: from human disease to molecular mechanism
Cartwright, B. R., & Goodman, J. M. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r023754 · Cited by 157
Precision medicine advances in idiopathic pulmonary fibrosis
Karampitsakos, Τ., Juan-Guardela, B. M., Τzouvelekis, Α., & Herazo‐Maya, J. D. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104766 · Cited by 157
Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression
Chien, J. W., Richards, T. J., Gibson, K. F., Zhang, Y., Lindell, K. O., Shao, L., Lyman, S. K., Adamkewicz, J. I., Smith, V., Kaminski, N., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00141013 · Cited by 156
Oda, T., Ogura, T., Kitamura, H., Hagiwara, E., Baba, T., Enomoto, Y., Iwasawa, T., Okudela, K., Takemura, T., Sakai, F., et al. (2014) · CHEST Journal · doi:10.1378/chest.13-2866 · Cited by 156
Cigna, N., Moshai, E. F., Brayer, S., Marchal-Sommé, J., Wémeau-Stervinou, L., Fabre, A., Mal, H., Lesèche, G., Dehoux, M., Soler, P., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.08.019 · Cited by 155
Yao, L., Conforti, F., Hill, C. N., Bell, J., Drawater, L., Li, J., Liu, D., Xiong, H., Alzetani, A., Chee, S., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0175-7 · Cited by 155
Self-citationPeljto, A. L., Selman, M., Kim, D. S., Murphy, E., Tucker, L., Pardo, A., Lee, J. S., Ji, W., Schwarz, M. I., Yang, I. V., et al. (2014) · CHEST Journal · doi:10.1378/chest.14-0867 · Cited by 154
Self-citationBlood Biomarkers MMP-7 and SP-A
Song, J. W., Do, K., Jang, S. J., Colby, T. V., Han, S., & Kim, D. S. (2013) · CHEST Journal · doi:10.1378/chest.11-2735 · Cited by 154
Self-citationLee, T., Park, J. Y., Lee, H. Y., Cho, Y.-J., Yoon, H. I., Lee, J. H., Jheon, S., Lee, C.-T., & Park, J. S. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.07.020 · Cited by 154
The potential of mesenchymal stem cell therapy for chronic lung disease
Cruz, F. F., & Rocco, P. R. M. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1679628 · Cited by 154
Gunnarsson, R., Molberg, Ø., Gilboe, I., & Gran, J. T. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.143792 · Cited by 154
Rao, L.-Z., Wang, Y., Zhang, L., Wu, G., Zhang, L., Wang, F.-X., Chen, L.-M., Sun, F., Jia, S., Zhang, S., et al. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00650-6 · Cited by 153
Hecker, L. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00275.2017 · Cited by 153
Kuwano, K., Araya, J., Hara, H., Minagawa, S., Takasaka, N., Ito, S., Kobayashi, K., & Nakayama, K. (2016) · Respiratory Investigation · doi:10.1016/j.resinv.2016.03.010 · Cited by 153
Mankikian, J., Caille, A., Reynaud‐Gaubert, M., Agier, M., Bermudez, J., Bonniaud, P., Borie, R., Brillet, P., Cadranel, J. L., Court‐Fortune, I., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.02071-2022 · Cited by 153
Predictors of benefit following pulmonary rehabilitation for interstitial lung disease
Holland, A. E., Hill, C. J., Glaspole, I., Goh, N. S. L., & McDonald, C. F. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.11.014 · Cited by 152
Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature
Kistler, K. D., Nalysnyk, L., Rotella, P., & Esser, D. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-139 · Cited by 151
Esposito, D. B., Lanes, S., Donneyong, M., Holick, C. N., Lasky, J. A., Lederer, D., Nathan, S. D., O’Quinn, S., Parker, J., & Tran, T. N. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0818oc · Cited by 151
Self-citationCombination therapy: the future of management for idiopathic pulmonary fibrosis?
Wuyts, W. A., Antoniou, K. M., Borensztajn, K., Costabel, U., Cottin, V., Crestani, B., Grutters, J. C., Maher, T. M., Poletti, V., Richeldi, L., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70232-2 · Cited by 150
Self-citationGuiot, J., Cambier, M., Boeckx, A., Henket, M., Nivelles, O., Gester, F., Louis, E., Malaise, M., Dequiedt, F., Louis, R., et al. (2020) · Thorax · doi:10.1136/thoraxjnl-2019-214077 · Cited by 150
Transbronchial Cryobiopsy in Diffuse Parenchymal Lung Disease
Ussavarungsi, K., Kern, R. M., Roden, A. C., Ryu, J. H., & Edell, E. S. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.09.002 · Cited by 150
Self-citationChen, H., Chen, H., Liang, J., Gu, X., Zhou, J., Xie, C., Lv, X., Wang, R., Li, Q., Mao, Z., et al. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0371-7 · Cited by 149
Kim, S. Y., Diggans, J., Pankratz, D., Huang, J., Pagan, M., Sindy, N., Tom, E., Anderson, J. D., Choi, Y., Lynch, D. A., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00140-x · Cited by 149
Self-citationMortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
Zheng, Q., Cox, I. A., Campbell, J. A., Xia, Q., Otáhal, P., de Graaff, B., Corte, T. J., Teoh, A. K. Y., Walters, E. H., & Palmer, A. J. (2022) · ERJ Open Research · doi:10.1183/23120541.00591-2021 · Cited by 149
Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis
Günther, A., Korfei, M., Mahavadi, P., von der Beck, D., Ruppert, C., & Markart, P. (2012) · European Respiratory Review · doi:10.1183/09059180.00001012 · Cited by 149
Idiopathic Pulmonary Fibrosis and Lung Cancer. A Systematic Review and Meta-analysis
Brown, S.-A. W., Dobelle, M., Padilla, M. L., Agovino, M., Wisnivesky, J. P., Hashim, D., & Boffetta, P. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201807-481oc · Cited by 149
Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF)
Saito, S., Alkhatib, A., Kolls, J. K., Kondoh, Y., & Lasky, J. A. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.04.62 · Cited by 148
Self-citationMoon, S. W., Choi, J. S., Lee, S. H., Jung, K. S., Jung, J. Y., Kang, Y. A., Park, M. S., Kim, Y. S., Chang, J., & Kim, S. Y. (2019) · Respiratory Research · doi:10.1186/s12931-019-1001-6 · Cited by 148
Yamaguchi, T., Shimizu, J., Hasegawa, T., Horio, Y., Inaba, Y., Yatabe, Y., & Hida, T. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.10.001 · Cited by 148
Metadata
- Authors
- Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., Lynch, D. A., Ryu, J. H., Swigris, J. J., Wells, A. U., Ancochea, J., Bouros, D., Carvalho, C., Costabel, U., Ebina, M., Hansell, D. M., Johkoh, T., Kim, D. S., King, T. E., Kondoh, Y., Myers, J., Müller, N. L., Nicholson, A. G., Richeldi, L., Selman, M., Dudden, R. F., Griss, B. S., Protzko, S. L., & Schünemann, H. J.
- Affiliations
- University of Washington (US)
- University of California, San Francisco (US)
- Mater Misericordiae University Hospital (IE)
- Ludwig-Maximilians-Universität München (DE)
- Mayo Clinic (US)
- University of Michigan (US)
- Tulane University (US)
- University of Colorado Boulder (US)
- National Jewish Health (US)
- Royal Brompton Hospital (GB)
- Hospital Universitario de La Princesa (ES)
- University Hospital of Alexandroupolis (GR)
- Universidade de São Paulo (BR)
- Tohoku University (JP)
- Royal Brompton & Harefield NHS Foundation Trust (GB)
- The University of Osaka (JP)
- University of Ulsan (KR)
- University of Modena and Reggio Emilia (IT)
- Instituto Nacional de Enfermedades Respiratorias (MX)
- ORCID
- Raghu, Ganesh
- Collard, Harold R.
- Colby, Thomas V.
- Lasky, Joseph A.
- Lynch, David A.
- Ryu, Jay H.
- Swigris, Jeffrey J.
- Wells, Athol U.
- Ancochea, Julio
- Bouros, Demosthenes
- Carvalho, Carlos
- Costabel, Ulrich
- Johkoh, Takeshi
- King, Talmadge E.
- Kondoh, Yasuhiro
- Myers, Jeffrey
- Nicholson, Andrew G.
- Richeldi, Luca
- Selman, Moisés
- Schünemann, Holger J.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03
- Volume
- 183
- Issue
- 6
- Pages
- 788-824
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC5450933
- OpenAlex
- W2167383172
- Cited by
- 7,186
- References
- 325
- Citations by year
- 2026: 187 · 2025: 307 · 2024: 436 · 2023: 432 · 2022: 522 · 2021: 640 · 2020: 607 · 2019: 596 · 2018: 607 · 2017: 605 · 2016: 569 · 2015: 531 · 2014: 426 · 2013: 370 · 2012: 256
- FWCI
- 304.18
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Funders
- National Heart, Lung, and Blood Institute (K23HL092227)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, diagnosis, management, natural history (disease), staging, prognosis, risk factors, treatment, disease surveillance, GRADE
- MeSH terms
- Europe, Humans, International Cooperation, Japan, Latin America, Societies, Medical, United States, Evidence-Based Medicine, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.